CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Other disposition See Remarks disposed of 2,000 shares (other)
- 4 Planned sale Director sold 15,500 shares at $7.72 ($119,610)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 42,232 shares at $7.92 ($334,515)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 107,500 shares at $7.32 ($786,459)
- 4 Open-market sale Director sold 42,500 shares at $7.28 ($309,226)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes See Remarks gave up 36,918 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 14,651 shares (to pay taxes)
- 4 Open-market buy See Remarks bought 25,000 shares at $4.38 ($109,475)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
Page 6 of 18 · 346 filings